MEDICAMEN ORGANICS LTD (MEDIORG) reported revenue of ₹16.61 Cr and net profit of ₹1.51 Cr for the quarter ended 2024-09-30. Figures are parsed from the company's filed results.
The statements below are read from MEDICAMEN ORGANICS LTD’s filed results, 3 filed quarters and 3 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed Jul 18, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H2 FY25Mar 2025 | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|---|
| Sales | 21.6 | 17.9 | 4.78 | -77.9% |
| 17.7 | 14.4 | 12.0 | -32.5% | |
| Operating profit | 3.85 | 3.43 | -7.18 | -286.2% |
| OPM % | 17.9% | 19.2% | -150.2% | -168.1 pp |
| Other income | 0.05 | 0.06 | 0.02 | -59.9% |
| Interest | 0.29 | 0.33 | 0.38 | +28.7% |
| Depreciation | 0.37 | 0.41 | 0.48 | +30.0% |
| Profit before tax | 3.24 | 2.74 | -8.02 | n/m |
| Tax % | 21.8% | 25.6% | n/a (loss) | — |
| Net profit | 2.54 | 2.04 | -6.06 | n/m |
| EPS (₹) | 2.19 | 1.74 | -5.15 | n/m |
